Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program

被引：0

作者：

Giovanni Grignani

Vanna Chiarion Sileni

Carmine Pinto

Roberta Depenni

Nicola Fazio

Luca Galli

Dario Giuffrida

Carlo Carnaghi

Domenico Ciliberto

Domenico C. Corsi

Paola Queirolo

Elena Benincasa

Filippo Venturini

Gennaro Fazzi

Nuno Costa

Paolo Antonio Ascierto

机构：

[1] Candiolo Cancer Institute,Medical Oncology Unit

[2] FPO - IRCCS,Department of Medical Oncology

[3] Istituto Oncologico Veneto,Department of Medical Oncology

[4] Istituto di Ricovero e Cura a Carattere Scientifico,Division of Medical Oncology

[5] Clinical Cancer Centre,Medical Oncology Unit, Department of Experimental and Clinical Medicine

[6] IRCCS–AUSL di Reggio Emilia,Medical Oncology Unit

[7] University Hospital of Modena and Reggio Emilia,Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors

[8] European Institute of Oncology,undefined

[9] IEO,undefined

[10] IRCCS,undefined

[11] Azienda Ospedaliero-Universitaria Pisana and University of Pisa,undefined

[12] Istituto Toscano Tumori,undefined

[13] Istituto Oncologico del Mediterraneo,undefined

[14] Ospedale Centrale di Bolzano,undefined

[15] Magna Graecia University,undefined

[16] Ospedale San Giovanni Calibita,undefined

[17] Fatebenefratelli,undefined

[18] European Institute of Oncology,undefined

[19] IEO,undefined

[20] IRCCS,undefined

[21] Merck KGaA,undefined

[22] Merck Serono SpA,undefined

[23] Rome,undefined

[24] Italy; an affiliate of Merck KGaA,undefined

[25] Pfizer Inc,undefined

[26] Istituto Nazionale Tumori IRCCS Fondazione G. Pascale,undefined

来源：

Journal of Translational Medicine | / 19卷

关键词：

Avelumab; Merkel cell carcinoma; Second line; Expanded access program; PD-L1;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program
Grignani, Giovanni
Sileni, Vanna Chiarion
Pinto, Carmine
Depenni, Roberta
Fazio, Nicola
Galli, Luca
Giuffrida, Dario
Carnaghi, Carlo
Ciliberto, Domenico
Corsi, Domenico C.
Queirolo, Paola
Benincasa, Elena
Venturini, Filippo
Fazzi, Gennaro
Costa, Nuno
Ascierto, Paolo Antonio
JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
[2] Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
Walker, John W.
Lebbe, Celeste
Grignani, Giovanni
Nathan, Paul
Dirix, Luc
Fenig, Eyal
Ascierto, Paolo Antonio
Sandhu, Shahneen
Munhoz, Rodrigo
Benincasa, Elena
Flaskett, Sarah
Reed, Josh
Engelsberg, Arne
Hariharan, Subramanian
Kasturi, Vijay
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[3] Avelumab treatment of Australian patients with metastatic Merkel cell carcinoma (mMCC): Experience from an expanded access program (EAP)
van Hagen, Tom
Sandhu, Shahneen
Kasturi, Vijay
Steer, Christopher
Khoo, Chloe
Nordman, Ina
Hennessy, Meliessa
Hildemann, Steven
Reed, Josh
Hariharan, Subramanian
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 173 - 174
[4] Second-line avelumab treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from a global expanded access program (EAP)
Walker, John
Kasturi, Vijay
Lebbe, Celeste
Sandhu, Shahneen Kaur
Grignani, Giovanni
Hennessy, Meliessa G.
Hildemann, Steven
Reed, Josh
Hariharan, Subramanian
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[5] Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad hoc expanded access program (EAP)
Ascierto, P. A.
Nathan, P.
Kasturi, V.
Dirix, L. Y.
Fenig, E.
Hennessy, M.
Reed, J.
Engelsberg, A.
Hariharan, S.
Lebbe, C.
ANNALS OF ONCOLOGY, 2018, 29 : 29 - 29
[6] Avelumab treatment of metastatic merkel cell carcinoma (mMCC): Updated findings from Australian patients enrolled in an expanded access program(EAP)
Sandhu, Shahneen
Kasturi, Vijay
Guminski, Alex
Steer, Christopher
Atkinson, Victoria
Nordman, Ina
Tobin, Peter
Reed, Josh
Costa, Nuno
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 184 - 184
[7] Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad-hoc expanded access program (EAP)
Nathan, P.
Kasturi, V.
Dirix, L.
Fenig, E.
Ascierto, P. A.
Hennessy, M.
Reed, J.
Engelsberg, A.
Hariharan, S.
Lebbe, C.
ANNALS OF ONCOLOGY, 2018, 29
[8] Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East
Ascierto, Paolo Antonio
Orlova, Kristina
Grignani, Giovanni
Dudzisz-Sledz, Monika
Fenig, Eyal
Sileni, Vanna Chiarion
Fazio, Nicola
Samimi, Mahtab
Mortier, Laurent
Gebhardt, Christoffer
Kramkimel, Nora
Steven, Neil
Bechter, Oliver
Arance, Ana
Benincasa, Elena
Kostkova, Lenka
Costa, Nuno
Lorigan, Paul
INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (11) : 1926 - 1934
[9] Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program (vol 8, e000313, 2020)
Walker, J. W.
Lebbe, C.
Grignani, G.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[10] Avelumab for the treatment of metastatic Merkel cell carcinoma
Cordes, L. M.
Gulley, J. L.
DRUGS OF TODAY, 2017, 53 (07) : 377 - 383

← 1 2 3 4 5 →